Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1335
    Keywords: Key words Fludarabine monophosphate  ; Radiation  ;  Cytotoxic effects  ;  Synergism  ; Carcinoma cells
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Purpose: Fludarabine monophosphate (fludarabine-P) is a relatively new drug in the treatment of different haematological diseases. The mechanism of action also implies a possible role of this drug as a radiosensitizer. Up to now no in vitro investigations dealing with radiosensitizing effects of fludarabine-P in carcinoma cell lines and fibroblasts have been published. The aim of our studies was to analyse the cytotoxic and radiosensitizing effects of different dosages and application schedules of fludarabine-P in a human squamous carcinoma cell line of the oropharynx (ZMK-1) and of fetal lung fibroblasts (MRC-5) in vitro. Possible mechanisms of interaction of fludarabine-P and radiation were investigated. Methods: ZMK-1 and MRC-5 cells were cultured under standard conditions with different concentrations of fludarabine-P in combination with escalating doses of radiation. Cytotoxic effects were measured by colony-forming assays. Induction and rejoining of radiation-induced DNA double-strand breaks after incubation with fludarabine-P were measured using constant-field gel electrophoresis. Incubation times for rejoining varied from 0 h to 24 h. Results: Fludarabine-P showed a radiosensitizing activity in ZMK-1 tumour cells and MRC-5 fibroblasts. The observed effects depended on the concentration and the incubation time. The largest effect was demonstrable for an incubation of 5 days, which started shortly before irradiation, whereas an incubation solely before irradiation did not have a clear effect on the cellular survival. The sensitizer enhancement ratio, at the 10% survival level, in the ZMK-1 cells was 2.2 in comparison to 1.6 in MRC-5 cells. The analysis of the interaction of fludarabine-P and ionising radiation by means of the isobologram approach, revealed an overadditive effect in the tumour cell line and an additive effect in the lung fibroblasts. Fludarabine-P did not modify the rejoining of radiation-induced DNA double-strand breaks in either cell line. Conclusions: We conclude that fludarabine-P in clinically attainable doses is a strong radiosensitizer in ZMK-1 cells and has a lower activity in the MRC-5 fibroblasts in vitro. The radiosensitization of fludarabine-P seems to be over additive in the malignant cells and additive in normal fetal fibroblasts. This would indicate that fludarabine-P might enhance the therapeutic ratio of radiation. Further investigations are warranted to identify the potential of this drug as a radiosensitizer in vivo and to elucidate the mechanism of interaction of the drug and radiation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1335
    Keywords: Key words Paclitaxel ; Radiotherapy ; Radiosensitizer ; Cell culture
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background and purpose : The anticancer drug paclitaxel, a natural product from Taxus brevifolia, is a microtubule-stabilising agent, which has been shown to block different cells in the G2/M phase of the cell cycle and so modulate their radioresponsiveness. We investigated the radiosensitizing potential of paclitaxel in human head and neck cancer cells (ZMK-1), in cervical squamous cell carcinoma cells (CaSki) and in breast adenocarcinoma cells (MCF-7). Methods: ZMK-1 cells were incubated with paclitaxel for 3, 9, or 24 h before irradiation. ZMK-1-, CaSki- and MCF-7 cells were incubated with paclitaxel for 24 h after irradiation. The paclitaxel concentration (70 nM, 7 nM, 0.7 nM) was chosen to obtain equivalent toxicity at the different incubation times (3 h, 9 h, 24 h respectively). Radiation doses were from 0 to 8 Gy. Cell survival was measured by a standard clonogenic assay after a 9-day incubation. Flow cytometry was used to measure the capacity of paclitaxel to cause accumulation of cells in the G2/M phase of the cell cycle. Results: Paclitaxel alone was cytotoxic in a time- and concentration-dependent manner. Up to 36% of the ZMK-1 cells accumulated in G2/M after treatment for 24–36 h. If the cells were incubated with paclitaxel before irradiation the isoeffect enhancement ratios for ZMK-1 cells, determined at the 37% survival level, were 0.81, 1.48 and 1.15 for 3-h, 9-h, and 24-h pre-incubations respectively. For a paclitaxel incubation of 24 h after irradiation, the isoeffect enhancement ratios, determined at the 37% survival level, were 0.72, 0.76 and 1.2 for the ZMK-1, CaSki, and MCF-7 cells respectively. Conclusion: In the three cell lines no radiosensitizing effect of paclitaxel could be demonstrated unambiguously. The use of asynchronized cells or the support of cellular repair mechanisms while the cells are blocked in G2/M could partly explain the results.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-1335
    Keywords: Key words Interferon ; Recombinant beta-interferon ; Radiation ; Cytokines ; Radiosensitization ; Lung cancer
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Purpose : The enhancing effect of natural interferon-β (n-IFN-β) or recombinant interferon-β (r-IFN-β) on radiation damage in tumor cells has been evaluated in several sudies. It is not clear whether the different forms of IFN-β available today are equally efficient in modulating the intrinsic radiosensitivity of tumor cells. The purpose of this study was to compare the radiosensitizing effect of n-IFN-β, r-IFN-β1a, and r-IFN-β1b in one cancer cell line. Methods : The A549 lung-cancer cell line was grown as a monolayer culture and incubated for 24 h with n-IFN-β (Fiblaferon), r-IFN-β1a (Betaserin), or r-IFN-β1b (Betaferon). Thereafter, the cultures were irradiated with single graded doses of 0, 1, 2, 4, and 6 Gy. Cellular survival was counted in a colony-forming assay at 10 days after treatment. Survival curves were established using the linear quadratic model. Statistical comparison of the survival data was performed using Student's t-test for each dose point. Interactions of IFN-β and radiation were evaluated using isobologram analysis. Results : All three types of IFN-β enhanced the radiation sensitivity of A549 cells in a similar way as shown in the alteration of the survival curves and the isobologram analysis. The isoeffective concentration of r-IFN-β1b was 2.7-fold higher than that of r-IFN-β1a or n-IFN-β. All three interferons increased the α-component of the survival curves in a concentration-dependent way, suggesting an influence on repair of radiation damage. The maximal sensitizing enhancement ratio (SER) obtained with n-IFN-β or r-IFN-β1a at 3000 IU/ml was 1.66 and 1.51, respectively. The highest SER, obtained with r-IFN-β1b, at 8000 IU/ml was 1.93. Conclusions : All three interferons tested can equally modify the intrinsic radiosensitivity of A549 cells. The isoeffective concentration of r-IFN-β1b is 2.7-fold that of n-IFN-β or r-IFN-β1a.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1573-7373
    Keywords: animal model ; leptomeningeal metastasis ; lymphomatous meningitis ; intrathecal therapy ; immunotherapy ; immunotoxin
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract We have established a new xenogeneic animal model of leptomeningeal metastasis (LM) by intracisternal inoculation of human CEM T-cell lymphoma into nude rats, and used it to evaluate the anti-lymphoma efficacy of an anti-CD7 ricin A chain immunotoxin (DA7). In vitro incubation with 2 μg/ml DA7 for 72 h inhibited CEM cells by 90% in a trypan blue exclusion assay. To establish its anti-lymphoma activity, one and four days after cisternal inoculation of 106 CEM cells, eight animals each were treated cisternally with 10 μg DA7 in 50 μl PBS or sham-treated with 50 μl PBS. Histopathologically, all eight sham-treated and five of eight DA7 treated animals showed typical features of LM with multilayers of tumor cells along the whole subarachnoid space and the ventricular walls, as well as subependymal and diffuse parenchymal tumor cell infiltration. Three DA7 treated animals were free of tumor. Two of these animals were asymptomatic long-term survivors (〉 90 days). The third tumor-free animal suddenly died on day 51. Histology revealed viral myocarditis. Median symptom-free survival was 51 days (range 29–90+ days) in DA7 treated and 34 days (range 29–87 days) in sham-treated animals (p=0.12, log-rank test). Histologically, no signs of neurotoxicity or systemic toxicity was found. However, DA7 treated animals showed a tendency to a slower weight increase on days 6–28 after tumor cell inoculation. Our results indicate that this model is useful in studying leptomeningeal seeding and intracisternal treatment of lymphoma. The demonstrated anti-tumor effect of DA7 treatment deserves further evaluation especially regarding the application of DA7 in early stages of LM from T-cell lymphoma.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1573-7373
    Keywords: leptomeningeal metastasis ; meningeal carcinomatosis ; B16 melanoma ; intrathecal chemotherapy ; ACNU
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary To evaluate new cytotoxic drugs for intrathecal treatment we developed an experimental model of leptomeningeal metastasis by intracisternal injection of 104B16-F10 melanoma cells in nude rats. One hour in vitro incubation with 20 μg/ml ACNU (area under the drug concentration-time curve = 1200 μgxmin/ml) induced a 4-log kill of B16 melanoma cells. A single or repeated non-toxic dose of 1 mg/kg was injected into the cisterna magna of rats inoculated with tumor (area under the drug concentration-time curve assuming an even cerebrospinal fluid distribution 〉 7000 μgxmin/ml). Median survival free of symptoms was 16 days (range 14–27) for controls (n = 9) and 18 days (range 17–23) for rats treated with ACNU on day 4 (n = 9). Animals treated both on day 2 and 8 (n = 8) developed symptoms on day 21 (range 13–35). Neurological symptoms and neuropathological examination in animals with increased survival indicated local suppression of tumor growth in the cisterna magna but increased spinal seeding and mass growth. From these results and the available pharmacokinetic data on ACNU it is concluded that bolus injection of ACNU — although locally effective — is not a sufficient treatment of widespread leptomeningeal metastasis. An increased therapeutic efficacy might be achieved by ventriculolumbar perfusion.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1439-099X
    Keywords: Schlüsselwörter: Testikuläre Keimzelltumoren ; Evidenzbasierte Medizin (EBM) ; Interdisziplinäre Diagnostik- und Therapieempfehlungen ; Key Words: Testicular germ cell tumors ; Evidence-based medicine (EBM) ; Interdisciplinary diagnostic and treatment strategies
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Background: An “Interdisciplinary Consensus Statement on the Diagnosis and Therapy of Testicular Tumors” was prepared in 1996 by the “Interdisciplinary Testicular Tumor Working Group” (IAH) with input from representatives from diagnostic and therapeutic disciplines of various working groups of the German Cancer Society (Strahlenther Onkol 1997;173:397–406). In 1998 the IAH met again together with the “Testicular Tumor Working Party” of the Urooncology Working Group (AUO) and formed the “German Testicular Cancer Study Group (GTCSG). Defined and accepted interdisciplinary standards from the initial meeting were revised based on current scientific developments and clinical results. This cooperating effort increases the quality of the initial recommendations and helped to put the recommendations for diagnosing and treating testicular on a broader scientific basis. Methods: According to the principles of “evidence-based medicine” (EBM), the Consensus from 1996 was modified, based on the current level of evidence from the published literature. The methodological process and evaluation criteria used were that of the “Cochrane Collaboration”. Results: An “Interdisciplinary Update Consensus Statement” summarizes and defines the diagnostic and therapeutic standards according to the current scientific practices in testicular cancer. For 21 separate areas scientifically based decision criteria are suggested. For treatment areas where more than one option exist without a consensus being reached for a preferred strategy, such as in seminoma in clinical Stage I or in non-seminoma Stages CS I or CS IIA/B, all acceptable alternative strategies with their respective advantages and disadvantages are presented. This “Interdisciplinary Update Consensus” was presented at the 24th National Congress of the German Cancer Society on March 21st and subsequently evaluated and approved by the various German scientific medical societies.
    Notes: Hintergrund: 1996 war von der “Interdisziplinären Arbeitsgruppe Hodentumoren” (IAH), in der Vertreter aller an der Diagnostik und Therapie des germinalen Hodentumors beteiligten Disziplinen aus den jeweiligen Fachgesellschaften und Arbeitsgruppen der Deutschen Krebsgesellschaft zusammenarbeiten, ein “Interdisziplinärer Konsensus zur Diagnostik und Therapie von Hodentumoren” erarbeitet worden (Strahlenther Onkol 1997;173–406). Die seinerzeit in interdisziplinärer Abstimmung definierten Empfehlungen wurden aufgrund fortschreitender Entwicklungen und klinischer Erkenntnisse dem aktuellen Wissensstand angepasst und überarbeitet. Hierfür sind durch den 1998 erfolgten Zusammenschluss der IAH mit der “Organgruppe Hodentumoren” der Arbeitsgemeinschaft Urologische Onkologie (AUO) zur “German Testicular Cancer Study Group (GTCSG) die wissenschaftliche Basis erweitert und die Qualität der erabeiteten diagnostischen und therapeutischen Standards für Hodentumoren erhöht worden mit der Zielsetzung, eine breite Umsetzung der interdisziplinär erstelltn Empfehlungen zu ermöglichen. Methodik: In Erweiterung der Erarbeitung des Konsensus von 1996 erfolgte die Überarbeitung auf Grundlage aktueller Literaturdaten in Anlehnung an die Prinzipien der “Evidence-bases Medicine” (EBM). Aussagen und Empfehlungen zu den von interdisziplinär besetzten Arbeitsgruppen recherchierten Themenkomplexen wurden nach dem Grad ihrer Qualität und Sicherheit bewertet. Das methodische Vorgehen entsprach dabei dem der Cochrane Collaboration, deren Bewertungskriterien übernommen wurden. Ergebnisse: Der zu 21 Themenkomplexen anhand wissenschaftliche begründeter Entscheidungskriterien erarbeitete “Interdisziplinärer Update-Konsensus” präzisiert und definiert diagnostische und therapeutischen Standards entsprechend dem aktuellen Wissensstand über diese Tumorentität. Für Therapiesituationen, bei denen mehrere Optionen bestehen und kein Konsens über die favorisierte Strategie erzielt wurde wie beim Seminom in klinischen Stadium I oder beim Nichtseminom in den Stadien CS I bzw. CS IIA/B, wurden jeweilige Alternativen mit deren Vor- und Nachteilen dargestellt. Der “Interdisziplinäre Update-Konsensus” wurde beim 24. Deutschen Krebskongress am 21.3.2000 vorgestellt, nachfolgend von den daran beteiligten wissenschaftlichen Fachgesellschaften geprüft und gebilligt.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...